Antitumor activity of combinations of anti-HER-2 antibody trastuzumab and oral fluoropyrimidines capecitabine/5?-dFUrd in human breast cancer models
- 1 March 2002
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 49 (3) , 211-216
- https://doi.org/10.1007/s00280-001-0401-7
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: